Clinical Trials Directory

Trials / Completed

CompletedNCT02059369

Ablation of Complex Fractionated Electrograms With or Without Additional Linear Lesions for Persistent Atrial Fibrillation

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
90 (estimated)
Sponsor
Deutsches Herzzentrum Muenchen · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

While there is a consensus to perform pulmonary vein isolation (PVI) as a cornerstone for paroxysmal and persistent atrial fibrillation (AF), different additional ablation approaches are used for substrate modification: linear lesions, ablation of complex fractionated atrial electrograms (CFAE) or a combination of both. The aim of this study is to determine whether there is a difference in terms of freedom from arrhythmia recurrence between PVI with CFAE ablation in combination or not with linear lesions in patients with persistent AF.

Conditions

Interventions

TypeNameDescription
PROCEDUREPVI+CFAE+DCCpulmonary vein Isolation (PVI), CFAE for substrate modification and direct current cardioversion (DCC) if AF persists
PROCEDUREPVI, CFAE, anterior and roof line, DCCPVI, CFAE ablation. If AF persists linear lesions (anterior and roof line), cardioversion if AF persists

Timeline

Start date
2012-08-01
Primary completion
2014-07-01
Completion
2014-12-01
First posted
2014-02-11
Last updated
2017-04-11

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT02059369. Inclusion in this directory is not an endorsement.